BofA/Merrill Lynch Downgrades VWR Corp. (VWR) to Neutral
- Futures inch higher in run-up to corporate earnings
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises on robust EU data as Mideast tensions linger
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
VWR (VWR) Tops Q3 EPS by 1c
November 3, 2016 8:59 AM EDTVWR (NASDAQ: VWR) reported Q3 EPS of $0.44, $0.01 better than the analyst estimate of $0.43. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.15 billion.VWR reaffirmed FY2016 guidance.
Acquisition:
VWR also announced the acquisition of two companies, Reliable Biopharmaceutical and BioArra, earlier today.
... More